[go: up one dir, main page]

IL79521A0 - Pharmaceutical dosage unit of tissue plasminogen activator - Google Patents

Pharmaceutical dosage unit of tissue plasminogen activator

Info

Publication number
IL79521A0
IL79521A0 IL79521A IL7952186A IL79521A0 IL 79521 A0 IL79521 A0 IL 79521A0 IL 79521 A IL79521 A IL 79521A IL 7952186 A IL7952186 A IL 7952186A IL 79521 A0 IL79521 A0 IL 79521A0
Authority
IL
Israel
Prior art keywords
dosage unit
pharmaceutical dosage
plasminogen activator
tissue plasminogen
tissue
Prior art date
Application number
IL79521A
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Priority to IL79521A priority Critical patent/IL79521A0/en
Publication of IL79521A0 publication Critical patent/IL79521A0/en

Links

IL79521A 1985-07-29 1986-07-25 Pharmaceutical dosage unit of tissue plasminogen activator IL79521A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL79521A IL79521A0 (en) 1985-07-29 1986-07-25 Pharmaceutical dosage unit of tissue plasminogen activator

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75978585A 1985-07-29 1985-07-29
IL79521A IL79521A0 (en) 1985-07-29 1986-07-25 Pharmaceutical dosage unit of tissue plasminogen activator

Publications (1)

Publication Number Publication Date
IL79521A0 true IL79521A0 (en) 1986-12-31

Family

ID=26321569

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79521A IL79521A0 (en) 1985-07-29 1986-07-25 Pharmaceutical dosage unit of tissue plasminogen activator

Country Status (1)

Country Link
IL (1) IL79521A0 (en)

Similar Documents

Publication Publication Date Title
NZ216306A (en) Pharmaceutical compositions containing tissue plasminogen activator
AU567236B2 (en) Pharmaceutical formulation of tissue plasminogen activator
GB2184016B (en) Therapeutic device for the administration of medicaments
GB2199031B (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
GB8609219D0 (en) Transdermal delivery of drugs
GB2181346B (en) Pharmaceutical compositions and medical uses of dioxopiperidine derivatives
ZA865652B (en) Pharmaceutical dosage unit
GB8601389D0 (en) Treating pharmaceutical dosage forms
EP0428585A4 (en) Novel method of administering aspirin and dosage forms containing same
GB2192134B (en) Transdermal delivery of drugs
GR3030150T3 (en) Use of Human Interferon-Beta 2A for the preparation of medicaments
IL80302A0 (en) Biologically active derivatives of human epsilon-interferon
PT83016A (en) Process for the preparation of substituted benzamides and benzoates having pharmaceutical activity
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator
IL79521A0 (en) Pharmaceutical dosage unit of tissue plasminogen activator
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
EP0225177A3 (en) Dna sequence coding for human tissue plasminogen activator
GB8812621D0 (en) Pharmaceutical composition containing combination of analgesic agents
IE870196L (en) Device for discharge of atomized medicament for inhalation¹air
GB8609317D0 (en) Treatment of keratinous materials
ZA862976B (en) Human tissue plasminogen activator mutants
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
ZA86774B (en) Method of analgesic treatment and pharmaceutical compositions
GB8912294D0 (en) Improving therapeutic effectiveness of drugs
GB8500798D0 (en) Treatment of psoriasis & pharmaceutical composition